Cargando…
Expert Consensus on Clinical Use of an Orally Administered Dexketoprofen Plus Tramadol Fixed-Dose Combination in Moderate-To-Severe Acute Pain: A Delphi Study
INTRODUCTION: In 2016, the orally administered fixed-dose combination of dexketoprofen 25 mg and tramadol 75 mg (DKP/TRAM FDC) was approved in Europe for short-term treatment of moderate-to-severe acute pain, an indication that encompasses a wide range of post-operative and non-surgical painful cond...
Autores principales: | Varrassi, Giustino, Coaccioli, Stefano, De-Andrés, Josè, Hanna, Magdi, Macheras, Giorgos, Montero, Antonio, Perrot, Serge, Piras, Vincenzo, Scarpignato, Carmelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822787/ https://www.ncbi.nlm.nih.gov/pubmed/31535328 http://dx.doi.org/10.1007/s12325-019-01096-0 |
Ejemplares similares
-
Tramadol/Dexketoprofen Analgesic Efficacy Compared with Tramadol/Paracetamol in Moderate to Severe Postoperative Acute Pain: Subgroup Analysis of a Randomized, Double-Blind, Parallel Group Trial—DAVID Study
por: Hanna, Magdi, et al.
Publicado: (2021) -
DANTE Study: The First Randomized, Double-Blind, Placebo and Active-Controlled, Parallel Arm Group Study Evaluating the Analgesic Efficacy and Safety of Dexketoprofen TrometAmol aNd Tramadol Hydrochloride Oral FixEd Dose Combination on Moderate to Severe Acute Pain in Patients with Acute Low Back Pain—Rationale and Design
por: Varrassi, Giustino, et al.
Publicado: (2022) -
Management of Acute Cancer Pain in Asia: An Expert Opinion on the Role of Tramadol/Dexketoprofen Fixed-Dose Combination
por: Tuan, Jeffrey, et al.
Publicado: (2023) -
Towards an Effective and Safe Treatment of Inflammatory Pain: A Delphi-Guided Expert Consensus
por: Varrassi, Giustino, et al.
Publicado: (2019) -
Tramadol/dexketoprofen (TRAM/DKP) compared with tramadol/paracetamol in moderate to severe acute pain: results of a randomised, double-blind, placebo and active-controlled, parallel group trial in the impacted third molar extraction pain model (DAVID study)
por: Gay-Escoda, Cosme, et al.
Publicado: (2019)